Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Comment by BioTeckon Aug 05, 2021 11:45pm
147 Views
Post# 33662045

RE:RE:RE:I think

RE:RE:RE:I thinkWait till they release news of a presentation or more IR expenditure. That'll move the price...downwards. None of the things posted in the msg previous are new. They have been making these promises for too long. Again, all unofficial promises. They can't even graduate to the TSX let alone the Nasdaq. Stir up some volume and let me slam the bids.
MoneyMouth wrote:
Maybe, but I mean this seems to be another great opportunity to buy if you believe Dr. T can deliver. Hopefully the pattern continues and we bounce off support here and head towards 1.60 again. Only issue is that before we usually had a reason to bounce off the support here. The first time was the private placement. The time in march was in anticipation of the hour and a half corporate presentation they did, and the third time was in anticipation for the thyroid presentation. This time, there is nothing concrete to buy in anticipation of. But there seems to be anticipation for a news release soon, I mean we haven't heard anything in a while and they don't usually go completely quiet for 2 months so we should hear of something eventually here, big or small.


<< Previous
Bullboard Posts
Next >>